Long-term compassionate use of cefiderocol to treat chronic osteomyelitis caused by extensively drug-resistant Pseudomonas aeruginosa and extended-spectrum-β-lactamase-producing Klebsiella pneumoniae in a pediatric patient

Alamarat, Zain I.Babic, Jessica T.Tran, Truc T.Wootton, Susan H.Dinh, An Q.Miller, William R.Hanson, Blake M.Wanger, Audrey R.Gary, Joshua L.Arias, Cesar APérez, Norma2020-05-112020-05-1120200066-4804https://hdl.handle.net/20.500.12495/2598application/pdfengLong-term compassionate use of cefiderocol to treat chronic osteomyelitis caused by extensively drug-resistant Pseudomonas aeruginosa and extended-spectrum-β-lactamase-producing Klebsiella pneumoniae in a pediatric patientarticleOsteomielitisKlebsiellaSalud del niñohttps://aac.asm.org/lookup/doi/10.1128/AAC.00059-20Long-term compassionate use of cefiderocol to treat chronic osteomyelitis caused by extensively drug-resistant Pseudomonas aeruginosa and extended-spectrum-β-lactamase-producing Klebsiella pneumoniae in a pediatric patientAcceso cerrado2019